Agilent Technologies Goodwill increased by 0.2% to $4.48B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $4.43B to $4.48B. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 4.4% CAGR.
High goodwill indicates a history of aggressive M&A; significant write-downs signal that acquired assets are underperforming expectations.
Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...
Common in industries with high M&A activity; peers are compared based on the ratio of goodwill to total equity.
goodwill| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.05B | $3.98B | $3.98B | $3.96B | $3.96B | $3.95B | $3.95B | $3.98B | $3.98B | $3.98B | $3.96B | $3.97B | $3.96B | $3.97B | $4.48B | $4.43B | $4.47B | $4.48B | $4.47B | $4.48B |
| QoQ Change | — | -1.9% | -0.0% | -0.3% | -0.2% | -0.2% | +0.1% | +0.8% | -0.1% | +0.1% | -0.6% | +0.2% | -0.1% | +0.1% | +12.9% | -1.1% | +1.0% | +0.0% | -0.0% | +0.2% |
| YoY Change | — | — | — | — | -2.4% | -0.7% | -0.6% | +0.5% | +0.6% | +0.9% | +0.2% | -0.4% | -0.4% | -0.5% | +13.1% | +11.6% | +12.9% | +12.9% | -0.1% | +1.2% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Life Sciences and Diagnostics Markets | — | — | — | $2.96B | $3.00B | $3.00B | $3.00B | $3.00B |
| Agilent CrossLab | $258.00M | $259.00M | $1.17B | $1.16B | $1.17B | $1.17B | $1.17B | $1.17B |
| Applied Markets | — | — | — | $304.00M | $308.00M | $309.00M | $309.00M | $316.00M |
| Diagnostics and Genomics | $2.12B | $2.12B | $2.64B | — | — | — | — | — |
| Life Sciences and Applied Markets | $1.58B | $1.58B | $1.58B | — | — | — | — | — |
| Total | $3.96B | $3.97B | $4.48B | $4.43B | $4.47B | $4.48B | $4.47B | $4.48B |